Seeing Is Believing
Currently, out of the existing stock ratings of Pete Stavropoulos - 16 which are a Buy (100%)
Analyst Pete Stavropoulos works at CANTOR FITZGERALD and is covering the Healthcare sector with 23 price targets and ratings displayed on 5 stocks.
Pete Stavropoulos's average stock forecast success ratio is 25% with an average time for price targets to be met of 48 days.
Most recent stock forecast was given on ARCT, Arcturus Therapeutics Holdings at 22-Aug-2023.
Analyst best performing recommendations are on PLRX.
The best stock recommendation documented was for PLRX at 7/26/2022. The price target of $36 was fulfilled within 184 days with a profit of $18.36 (104.08%) receiving and performance score of 5.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
16
$13.66 (583.76%)
22 days ago
0/2 (0%)
$12.98 (349.85%)
Buy
3 months 13 days ago
0/1 (0%)
$18.17 (83.23%)
Buy
30
$27.64 (1171.19%)
30
3 months 27 days ago
0/5 (0%)
$25.84 (697.34%)
Hold
4
$1.66 (70.94%)
3
4 months 4 days ago
1/2 (50%)
$0.31 (9.13%)
6
Hold
9
$7.23 (408.47%)
6 months 10 days ago
0/1 (0%)
$6.9 (328.57%)
Which stock is Pete Stavropoulos is most bullish on?
Which stock is Pete Stavropoulos is most reserved on?
What Year was the first public recommendation made by Pete Stavropoulos?